All News
Filter News
Found 2,994 articles
-
Datamonitor Report: World Congress On Osteoporosis Highlights Changing Face Of Bone Health
6/2/2010
-
Theratechnologies Inc. Announces Positive Vote by FDA Advisory Committee for Tesamorelin
5/28/2010
-
Roche Release: Phase III Study Showed First-Line Maintenance Use Of Mabthera Doubles Likelihood Of People With Follicular Lymphoma Living Without Their Disease Worsening
5/21/2010
-
Response Biomedical Granted Class 3 Medical Device License by Health Canada to Market RSV Assay in Canada
5/17/2010
-
Fate Therapeutics Appoints Tom Novak, Ph.D., as Vice President of Research and Drug Discovery
5/10/2010
-
Pharmasset, Inc. Announces Results of a 28-day Phase 2a Study with PSI-7977 for the Treatment of Chronic Hepatitis C Infection
5/4/2010
-
BELLUS Health and Celtic Therapeutics Enter Agreement Worth $20 Million for Drug candidate KIACTA(TM)
4/30/2010
-
PDL BioPharma, Inc. Announces First Quarter 2010 Financial Results
4/30/2010
-
Trimeris, Inc. Reports First Quarter 2010 FUZEON(R) Sales Results
4/15/2010
-
Synosia Therapeutics' SYN-115 Improves Motor and Non-Motor Function in Patients with Mild- to-Moderate Parkinson's Disease
4/14/2010
-
AEterna Zentaris Rises Nearly 9% on Initiation of Phase 3 Registration Trial with Perifosine in Refractory Advanced Colorectal Cancer
4/8/2010
-
TRANSGENE Reviews Product Pipeline, Provides a Business Update and Outlines its Corporate Strategy
3/22/2010
-
Crucell N.V.'s Supervisory Board Nominates Mr. W. Burns, Mr. J. Shannon And Mr. G. Siber As New Board Members
3/15/2010
-
EUSA Pharma Completes Establishment of Commercial Infrastructure With Appointment of President for Europe and International Region
3/8/2010
-
PTC Therapeutics, Inc. and Genzyme Corporation Announce Preliminary Results from the Phase 2b Clinical Trial of Ataluren; Primary Endpoint Does Not Reach Statistical Significance within Duration of Study
3/3/2010
-
PDL BioPharma, Inc. Announces Fourth Quarter and Full Year 2009 Financial Results and Provides First Quarter 2010 Revenue Guidance
3/3/2010
-
Merck & Co., Inc.'s GARDASIL(R) Approved by Health Canada for Males to Prevent Genital Warts
2/24/2010
-
BioPartnering North America(TM) (BPN) Sets the Stage for Partnering in 2010
2/17/2010
-
AEterna Zentaris Partner Keryx Biopharmaceuticals Announces Special Protocol Assessment Agreement with FDA for Phase 3 Trial of Perifosine (KRX-0401) in the Treatment of Patients with Refractory Metastatic Colorectal Cancer
2/3/2010
-
Trimeris, Inc. Reports Fourth Quarter 2009 FUZEON(R) Sales Results
2/3/2010